4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Barinthus Biotherapeutics plc (BRNS) operates in the Biotechnology industry and is headquartered in Germantown, United States with about 14 employees. Its market capitalization is roughly $31 million. In the fiscal year ended 2025-12-31, BRNS reported $0M in revenue and ($66M) in net income.
Barinthus Biotherapeutics plc, together with its subsidiaries, engages in the research, development, and commercialization of immunotherapies and vaccines in the United States and the United Kingdom.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $15M | $1M | $45M | — |
| Operating Income (EBIT) | ($64M) | ($52M) | ($80M) | ($3M) | — |
| Net Income | ($66M) | ($61M) | ($73M) | $5M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($11M) | ($6M) | ($11M) | ($10M) | ($22M) | — |
| Net Income | ($11M) | ($6M) | ($11M) | ($15M) | ($21M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $98M | $160M | $214M | $270M | — |
| Total Liabilities | $24M | $30M | $28M | $27M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BRNS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms